A detailed history of Pro Vise Management Group, LLC transactions in Elevance Health, Inc. stock. As of the latest transaction made, Pro Vise Management Group, LLC holds 21,808 shares of ELV stock, worth $8.13 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
21,808
Previous 21,202 2.86%
Holding current value
$8.13 Million
Previous $11.5 Million 1.29%
% of portfolio
0.91%
Previous 0.98%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$500.12 - $562.29 $303,072 - $340,747
606 Added 2.86%
21,808 $11.3 Million
Q2 2024

Aug 12, 2024

BUY
$497.49 - $547.8 $215,413 - $237,197
433 Added 2.08%
21,202 $11.5 Million
Q1 2024

May 09, 2024

BUY
$464.61 - $519.96 $838,621 - $938,527
1,805 Added 9.52%
20,769 $10.8 Million
Q4 2023

Feb 09, 2024

BUY
$433.51 - $488.06 $951,554 - $1.07 Million
2,195 Added 13.09%
18,964 $8.94 Million
Q3 2023

Nov 08, 2023

BUY
$414.13 - $475.93 $5.35 Million - $6.15 Million
12,913 Added 334.88%
16,769 $7.3 Million
Q2 2023

Aug 24, 2023

BUY
$436.33 - $496.2 $9,599 - $10,916
22 Added 0.57%
3,856 $1.71 Million
Q1 2023

May 05, 2023

SELL
$446.3 - $502.2 $200,835 - $225,990
-450 Reduced 10.5%
3,834 $1.76 Million
Q4 2022

Feb 09, 2023

SELL
$465.23 - $546.77 $787,169 - $925,134
-1,692 Reduced 28.31%
4,284 $2.2 Million
Q3 2022

Nov 09, 2022

SELL
$445.98 - $507.0 $285,427 - $324,480
-640 Reduced 9.67%
5,976 $2.72 Million
Q2 2022

Aug 08, 2022

SELL
$444.32 - $529.84 $379,004 - $451,953
-853 Reduced 11.42%
6,616 $3.19 Million
Q1 2022

Apr 27, 2022

SELL
$428.44 - $502.48 $167,948 - $196,972
-392 Reduced 4.99%
7,469 $3.67 Million
Q4 2021

Jan 18, 2022

SELL
$370.08 - $467.67 $20,354 - $25,721
-55 Reduced 0.69%
7,861 $3.64 Million
Q3 2021

Oct 20, 2021

SELL
$357.51 - $398.13 $28,600 - $31,850
-80 Reduced 1.0%
7,916 $2.95 Million
Q2 2021

Aug 06, 2021

SELL
$352.19 - $401.9 $37,684 - $43,003
-107 Reduced 1.32%
7,996 $3.05 Million
Q1 2021

Apr 22, 2021

BUY
$287.7 - $371.31 $294,317 - $379,850
1,023 Added 14.45%
8,103 $2.91 Million
Q4 2020

Jan 19, 2021

BUY
$270.17 - $333.15 $180,473 - $222,544
668 Added 10.42%
7,080 $2.27 Million
Q3 2020

Oct 26, 2020

BUY
$245.73 - $284.63 $964,981 - $1.12 Million
3,927 Added 158.03%
6,412 $1.72 Million
Q2 2020

Aug 07, 2020

BUY
$203.3 - $300.59 $41,879 - $61,921
206 Added 9.04%
2,485 $654,000
Q1 2020

May 07, 2020

BUY
$174.68 - $307.74 $57,644 - $101,554
330 Added 16.93%
2,279 $517,000
Q4 2019

Feb 11, 2020

BUY
$234.82 - $306.42 $14,089 - $18,385
60 Added 3.18%
1,949 $589,000
Q3 2019

Nov 13, 2019

BUY
$237.69 - $310.48 $27,334 - $35,705
115 Added 6.48%
1,889 $454,000
Q2 2019

Aug 09, 2019

BUY
$236.25 - $293.76 $419,107 - $521,130
1,774 New
1,774 $501,000
Q3 2018

Nov 05, 2018

SELL
$238.27 - $274.12 $4,765 - $5,482
-20 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$220.13 - $245.16 $4,402 - $4,903
20 New
20 $4.76 Million

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $89.5B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Pro Vise Management Group, LLC Portfolio

Follow Pro Vise Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Vise Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Vise Management Group, LLC with notifications on news.